LIN28A Monoclonal Antibody (6D1F9), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA515453-Each-of-1 | In Stock | ₹ 62,122.00 |
PIMA515453 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 62,122.00
GST (18%): ₹ 11,181.96
Total Price: ₹ 73,303.96
Antigen
LIN28A
Classification
Monoclonal
Concentration
1.0 mg/mL
Formulation
PBS with 0.03% sodium azide; pH 7.4
Gene Accession No.
Q9H9Z2
Gene Symbols
LIN28A
Immunogen
Purified recombinant fragment of LIN28 (aa93-209) expressed in E. Coli.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG1
Applications
ELISA, Immunocytochemistry, Western Blot
Clone
6D1F9
Conjugate
Unconjugated
Gene
LIN28A
Gene Alias
AL024421; CSDD1; ENSMUSG00000070700; FLJ12457; Gm10299; Lin28; LIN-28; lin-28 homolog A; lin-28 homolog A (C. elegans); Lin28a; lin-28A; Protein lin-28 homolog A; RGD1566408; RNA-binding protein LIN-28; sb:cb650; si:ch211-232d9.4; similar to RNA-binding protein LIN-28; testis expressed gene 17; testis-expressed protein 17; Tex17; ZCCHC1; zgc:55584; Zinc finger CCHC domain-containing protein 1; zinc finger, CCHC domain containing 1
Host Species
Mouse
Purification Method
Protein G
Regulatory Status
RUO
Gene ID (Entrez)
79727
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- MA5-15453 targets LIN28 in indirect ELISA, IF, ICC, and WB applications and shows reactivity with human samples
- The MA5-15453 immunogen is purified recombinant fragment of LIN28 (aa93-209) expressed in E
- Coli
- MA5-15453 detects LIN28 which has a predicted molecular weight of approximately 23kDa
- Lin28 is a transcription factor that was first identified through its key role in the pathway of developmental timing in C
- elegans
- The role of Lin28 in development suggested that it might be useful in the creation of stem cells that might be beneficial in cell replacement therapies in the treatment of several degenerative diseases
- Artificial stem cells, termed induced pluripotent stem (iPS) cells, can be created by expressing Lin28 in addition to the transcription factors POU5F1, Sox2, and NANOG in mouse fibroblasts
- More recently, experiments have demonstrated that iPS cells could be generated using expression plasmids expressing Lin28, Sox2, POU5F1 and c-Myc, eliminating the need for virus introduction, thereby addressing a safety concern for potential use of iPS cells in regenerative medicine.